1. Home
  2. GTY vs TSHA Comparison

GTY vs TSHA Comparison

Compare GTY & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$31.52

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.09

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTY
TSHA
Founded
1955
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
GTY
TSHA
Price
$31.52
$5.09
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$32.60
$11.63
AVG Volume (30 Days)
450.6K
1.9M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
5.92%
N/A
EPS Growth
8.00
5.56
EPS
0.79
N/A
Revenue
$221,727,000.00
$9,773,000.00
Revenue This Year
$9.39
N/A
Revenue Next Year
$7.83
$1,152.42
P/E Ratio
$39.78
N/A
Revenue Growth
9.02
17.28
52 Week Low
$25.39
$2.72
52 Week High
$36.83
$7.30

Technical Indicators

Market Signals
Indicator
GTY
TSHA
Relative Strength Index (RSI) 34.26 30.59
Support Level $28.72 $4.37
Resistance Level $33.90 $5.07
Average True Range (ATR) 0.53 0.24
MACD -0.02 -0.09
Stochastic Oscillator 0.00 2.33

Price Performance

Historical Comparison
GTY
TSHA

About GTY Getty Realty Corporation

Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: